| 1 |
29523357 | Cellular effects of AP102, a somatostatin analog with balanced affinities for the hSSTR2 and hSSTR5 receptors. | 2018 Apr |
1 |
| 2 |
28397723 | Short-term Preoperative Octreotide for Thyrotropin-secreting Pituitary Adenoma. | 2017 Apr 20 |
1 |
| 3 |
28434012 | Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma). | 2017 Apr 23 |
1 |
| 4 |
28507564 | Management of the hormonal syndrome of neuroendocrine tumors. | 2017 Apr 1 |
1 |
| 5 |
26940387 | The Modern Criteria for Medical Management of Acromegaly. | 2016 |
1 |
| 6 |
25658662 | Pasireotide (SOM230) prevents sulfonylurea-induced hypoglycemia in rats. | 2015 Mar |
1 |
| 7 |
25925002 | Docetaxel in combination with octreotide shows synergistic apoptotic effect by increasing SSTR2 and SSTR5 expression levels in prostate and breast cancer cell lines. | 2015 Jun |
1 |
| 8 |
25008035 | Cytoplasmic expression of SSTR2 and 5 by immunohistochemistry and by RT/PCR is not associated with the pharmacological response to octreotide. | 2014 Dec |
1 |
| 9 |
24634935 | Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, A Wnt/β-catenin pathway modulator. | 2013 Oct |
2 |
| 10 |
20826222 | Feeding responses to central administration of several somatostatin analogs in chicks. | 2011 Jan |
1 |
| 11 |
21086053 | In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5. | 2011 Jun |
1 |
| 12 |
21667819 | Somatostatin receptors SSTR2 and SSTR5 are expressed in the human thoracic duct. | 2011 Mar |
1 |
| 13 |
20464704 | Does the response of GH-secreting pituitary adenomas to octreotide depend on the cellular localization of the somatostatin receptor subtypes SSTR2 and SSTR5? | 2010 Mar-Apr |
3 |
| 14 |
19148511 | Somatostatin analogues inhibit cancer cell proliferation in an SSTR2-dependent manner via both cytostatic and cytotoxic pathways. | 2009 Feb |
1 |
| 15 |
19753537 | Expression of somatostatin receptor subtypes in human pituitary adenomas -- immunohistochemical studies. | 2009 Jul-Aug |
1 |
| 16 |
18299461 | Quantitative analysis of somatostatin receptor subtypes (1-5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR. | 2008 Mar |
1 |
| 17 |
17218727 | Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas. | 2007 Jan |
1 |
| 18 |
17984930 | Response of ACTH to octreotide in a probable corticotropic adenoma associated with Addison's disease. | 2007 Oct |
1 |
| 19 |
16809928 | Acromegaly: molecular expression of somatostatin receptor subtypes and treatment outcome. | 2006 |
1 |
| 20 |
16086874 | [Effect of HBV X gene transfection on octreotide-inhibited growth of hepatocellular carcinoma cell line HepG2]. | 2005 Aug |
1 |
| 21 |
15077912 | The role of somatostatin receptors in the medical treatment of acromegaly. | 2004 Feb |
1 |
| 22 |
15080778 | Octreotide long-acting repeatable and lanreotide Autogel are equally effective in controlling growth hormone secretion in acromegalic patients. | 2004 Apr |
1 |
| 23 |
15356066 | Activation of somatostatin-receptor subtype-2/-5 suppresses the mass, frequency, and irregularity of growth hormone (GH)-releasing peptide-2-stimulated GH secretion in men. | 2004 Sep |
1 |
| 24 |
21210566 | 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated monomeric [Tyr3]octreotide | 2004 |
1 |
| 25 |
21210567 | 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated dimeric [Tyr3]octreotide | 2004 |
1 |
| 26 |
21290628 | 68Ga-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Tyr-cyclo(DAB-Arg-cyclo(Cys-Phe-d-Trp-Lys-Thr-Cys)) | 2004 |
1 |
| 27 |
21290631 | 177Lu-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Tyr-cyclo(DAB-Arg-cyclo(Cys-Phe-d-Trp-Lys-Thr-Cys)) | 2004 |
1 |
| 28 |
22896864 | 64Cu-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2 | 2004 |
1 |
| 29 |
22896865 | 64Cu-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2 | 2004 |
1 |
| 30 |
23136680 | 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2 | 2004 |
1 |
| 31 |
23136682 | 68Ga-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2 | 2004 |
1 |
| 32 |
12721508 | Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas. | 2003 Apr |
1 |
| 33 |
11965602 | Radiolabeled peptides in diagnosis and tumor imaging: clinical overview. | 2002 Apr |
1 |
| 34 |
11231991 | Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas. | 2001 Jan |
5 |
| 35 |
11344389 | Distribution and functional significance of somatostatin receptors in malignant melanoma. | 2001 Apr |
1 |
| 36 |
10690891 | Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes. | 2000 Feb |
1 |
| 37 |
10975802 | Somatostatin through its specific receptor inhibits spontaneous and TNF-alpha- and bacteria-induced IL-8 and IL-1 beta secretion from intestinal epithelial cells. | 2000 Sep 15 |
1 |
| 38 |
9892014 | C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest. | 1999 Jan |
1 |
| 39 |
10100234 | Somatostatin receptor scintigraphy of a patient with a giant invasive prolactinoma. | 1999 |
1 |
| 40 |
9484822 | Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours. | 1998 Feb |
1 |
| 41 |
9753663 | Inhibition of L-type calcium channels by octreotide in isolated human neuroendocrine tumor cells of the gut. | 1998 Sep 18 |
1 |
| 42 |
8734455 | Somatostatin receptors and disease: role of receptor subtypes. | 1996 Jan |
1 |